GH secretagogue · Research compound

What is ipamorelin?

A selective growth-hormone secretagogue — a five-amino-acid peptide that prompts the pituitary to release growth hormone through the ghrelin receptor.

Reviewed against primary literature Last updated Jun 2026 For research use only

tuned Ipamorelin research vial, ≥99% purity

Purity · UPLC≥99%

In short

Ipamorelin is a selective growth-hormone (GH) secretagogue — a pentapeptide that switches on the ghrelin/GH-secretagogue receptor (GHSR) to trigger a pulse of the body's own growth hormone.[1] Its defining trait is selectivity: in the original pharmacology it raised GH about as strongly as older peptides like GHRP-6, but without the spike in cortisol, ACTH or prolactin they cause.[1] Most of its evidence is preclinical (cells and animals); controlled human data are limited.

01 — What it is

What is ipamorelin, exactly?

Ipamorelin is a small synthetic pentapeptide — a chain of five amino acids (Aib-His-D-2-Nal-D-Phe-Lys-NH₂) — designed to make the pituitary release growth hormone.[1] It belongs to a class called growth-hormone secretagogues (GHS), or growth-hormone-releasing peptides (GHRPs), which mimic the natural hunger hormone ghrelin at its receptor.

It was first described in 1998 by a Novo Nordisk group and introduced as "the first selective growth hormone secretagogue."[1] That word — selective — is the whole story of ipamorelin. Earlier secretagogues released GH but also nudged stress hormones; ipamorelin was engineered to release GH cleanly.

So ipamorelin isn't growth hormone itself, and it isn't a steroid. It's an upstream signal — a research peptide that asks the pituitary to do its own job, producing GH in natural-shaped pulses rather than flooding the system with hormone from outside.

02 — A common question

Is ipamorelin a peptide?

Yes — ipamorelin is a peptide. Specifically a pentapeptide: five amino acids joined in a short chain, with a couple of non-natural residues (Aib and D-amino acids) that make it more stable than an ordinary sequence.[1]

Because it's a peptide rather than a small-molecule drug, it behaves like the other research peptides in this catalogue: a lyophilized (freeze-dried) powder that is reconstituted for laboratory use, and one that the gut would largely break down — which is why it is studied as an injectable rather than a pill.

What is ipamorelin for men?

Search interest in "ipamorelin for men" reflects its popularity in male body-composition and recovery circles, where the GH–IGF-1 axis is of interest. The honest picture: ipamorelin's GH-releasing action is not sex-specific in the underlying pharmacology, and the controlled human evidence is limited for anyone. Any sex-specific framing online is community lore, not a finding from trials.

03 — What it does in the body

What does ipamorelin do?

The consistent theme across ipamorelin research is stimulating a pulse of growth hormone, and through it the downstream insulin-like growth factor 1 (IGF-1). The actions described in the literature are:

Releases growth hormone via the ghrelin receptor. Ipamorelin activates GHSR on pituitary cells, releasing GH with potency and efficacy comparable to GHRP-6 in the original animal and cell work.[1]
Does it selectively. Unlike GHRP-6 and GHRP-2, it did not meaningfully raise ACTH or cortisol even far above the GH-effective range — a cleaner hormonal profile.[1]
Counters muscle and bone loss in catabolic models. In steroid-treated rats it improved nitrogen balance and offset glucocorticoid-driven losses; in adult rats it counteracted steroid-induced declines in bone formation.[3][4]
Acts as a ghrelin mimetic on the gut. Its ghrelin-receptor activity has also been studied for gastrointestinal motility, e.g. in a rodent post-operative ileus model.[5]

The key caveat — stated plainly — is that the strongest data are in animals and cells. Ipamorelin reliably does something real to GH signalling in those models; whether that produces a given outcome in humans is a separate question that controlled trials have not closely answered.

04 — How it works

How does ipamorelin work?

Ipamorelin works at one specific switch: the growth-hormone-secretagogue receptor (GHSR) — the same receptor the hunger hormone ghrelin uses — on the GH-producing cells of the pituitary.

The selective GH-release mechanism

When ipamorelin binds GHSR, it triggers the pituitary's somatotrophs to release stored growth hormone in a pulse, which then drives IGF-1 production mainly in the liver.[1] Because it amplifies the body's own pulsatile rhythm rather than supplying a constant external hormone, the GH it releases follows a more natural shape. Research has mapped this across the GH–IGF-1 axis and the somatostatin receptors that normally brake GH.

Ipamorelin vs GHRP-6: the selectivity difference

This is the point that sets ipamorelin apart from older GHRPs. GHRP-6 and GHRP-2 release GH but also raise appetite and stress hormones (ACTH and cortisol). In the founding study, ipamorelin matched their GH-releasing efficacy while leaving ACTH and cortisol essentially unchanged — the basis for calling it the first selective secretagogue.[1] That cleaner profile is the main reason it remains a reference GHS in research.

GH secretagogue tuned Ipamorelin research vial

Research-grade · ≥99% purity

tuned Ipamorelin

5 MG lyophilized · batch-specific Certificate of Analysis

99% purity guaranteed

Same-day dispatch before 2 PM ET

Free shipment protection

3rd-party tested in the U.S.

View Ipamorelin ▸ How we test

For laboratory research use only · available to researchers. Specifications, pricing & Certificate of Analysis on the product page.

05 — Benefits

Ipamorelin benefits

The ipamorelin peptide benefits discussed in research all follow from one upstream action — a cleaner pulse of growth hormone and IGF-1 — and they are best read as research-stage, weighted toward preclinical evidence:

Lean mass & anti-catabolic signalling. In catabolic (steroid-treated) animal models, ipamorelin improved nitrogen balance and helped preserve tissue — a GH-mediated, anti-wasting effect.[3]
Bone. It induced longitudinal bone growth in young rats and counteracted glucocorticoid-driven loss of bone formation in adult rats.[2][4]
Recovery & sleep interest. Because GH is released in pulses tied to deep sleep, ipamorelin is popular in recovery and sleep-quality discussion — though this is mechanism-led extrapolation, not a proven clinical outcome.
Cleaner side-effect profile than older GHRPs. Its selectivity for GH over cortisol/ACTH is itself often framed as a benefit versus GHRP-6/2.[1]

Ipamorelin for muscle, recovery and sleep

The everyday framing of ipamorelin as a "lean muscle, recovery and sleep" peptide is consistent with GH biology, but it runs ahead of the human evidence. The controlled data sit largely in animals; the popular benefit claims are reasonable hypotheses, not validated results, and ipamorelin is not an approved treatment for any of them.

06 — Before & after

Ipamorelin before and after

"Ipamorelin before and after" results shared online are anecdotal — self-reported changes in body composition, recovery or sleep, often alongside training, diet changes or other compounds. They are not controlled data, the material and methods are unverified, and individual reports cannot establish cause and effect.

Female ipamorelin before and after

The same applies to "female ipamorelin before and after" reports. Ipamorelin's pharmacology isn't sex-specific in the founding research, and there is no controlled human trial isolating before-and-after outcomes by sex. We present this as community context, clearly separated from the peer-reviewed mechanism above — useful for understanding interest, not for predicting an outcome.

07 — Dosage

Ipamorelin dosage

There is no established human dose for ipamorelin. It is not an approved medicine, so there is no regulated dosage, and the figures circulated in bodybuilding communities are unverified vendor and forum conventions rather than clinical guidance. The original pharmacology that defined ipamorelin's GH-releasing potency was done in cells and animals.[1]

This page does not provide dosing amounts, syringe measurements, reconstitution instructions, or administration guidance. Questions about how a research compound is measured or prepared sit outside what this educational resource covers, and any number you find online for "ipamorelin dosage per day" should be treated as unverified.

08 — Safety & identity

Is ipamorelin safe?

The most honest answer is that safety in humans is not well established. Ipamorelin is a research chemical, not an approved drug; it has not been through the long-term human safety studies a medicine requires. Its theoretical appeal is the selectivity shown in early work — GH release without the cortisol and ACTH rise of older GHRPs — but a clean hormonal signature in animals is not the same as proven human safety.[1]

Ipamorelin side effects

Effects discussed in connection with GH secretagogues include water retention, headache, lightheadedness and changes in appetite or blood-sugar handling, reflecting GH/IGF-1 physiology; injection-site reactions are the practical risk for any injectable peptide. Most of this is mechanism-based or anecdotal rather than from controlled ipamorelin trials. For a fuller treatment, see the dedicated ipamorelin side effects guide.

How to choose ipamorelin

For a research peptide, material quality is the dominant variable — endotoxin and impurities, not the molecule, are the realistic risks. A batch-specific Certificate of Analysis (UPLC purity, identity by mass spec, endotoxin) does more for safety than any dosing convention; the absence of a recent, lot-matched CoA is itself a risk signal. On sport: GH secretagogues are prohibited in competition by WADA, so athletes should assume ipamorelin is banned and verify with their anti-doping authority.

Type

GH secretagogue

Length

5 amino acids

Target

GHSR (ghrelin receptor)

Class

GHRP / ghrelin mimetic